Recent content by Mitchell Florn

Classic psychedelics such as psilocybin, ketamine and lysergic acid diethylamide (LSD) are 5HT2A serotonin receptor agonists that produce individualised subjective affects. Today, public interest in psychedelic medicine has reached a fervour but the evidence for clinical benefit still lags...

Microdoses of psychedelics (i.e. a sub-hallucinogenic dose taken every third day) can reduce symptoms of depression, anxiety and stress according to anecdotal reports and observational studies. Research with medium to high doses of psilocybin points towards potential underlying mechanisms...

The use of low sub-perceptual doses of psychedelics ("microdosing") has gained popularity in recent years. Although anecdotal reports claim multiple benefits associated with this practice, the lack of placebo-controlled studies severely limits our knowledge of microdosing and its effects...

Cannabidiol (CBD) is the primary non-psychoactive chemical from Cannabis Sativa, a plant used for centuries for both recreational and medicinal purposes. CBD lacks the psychotropic effects of Δ9-tetrahydrocannabinol (Δ9-THC) and has shown great therapeutic potential. CBD exerts a wide spectrum...

Insomnia is the most prevalent sleep disorder, with few effective pharmacotherapies. Anecdotal reports and recent preclinical research suggest that cannabinol (CBN), a constituent of Cannabis sativa derived from delta-9-tetrahydrocannabinol, could be an effective treatment. Despite this, the...

Cancer patients who use cannabis to address their symptoms have less pain, sleep better, and after a few weeks of sustained use, appear to think more clearly. This study is among the first to assess how cannabis bought over the counter at dispensaries affects cancer symptoms or chemotherapy...

Researchers shed light on the enigma of cannabis users tending to be leaner and less diabetes-prone despite appetite stimulation. The study shows that cannabis exposure during adolescence disrupts energy balance and adipose organ (fat storage) homeostasis. Findings reveal regular cannabis usage...

THIS ARTICLE MAY HELP SHED SOME LIGHT ON CANNABIS USE PRE AND POST-PARTUM https://neurosciencenews.com/cud-pregnanct-mental-health-23832/

THE USE OF ETHANOL ( U.S.P. GRADE IS THE BEST) IS EXTREMELY SAFE TO USE FOR ORGANIC EXTRACTION....

HERE IS SOME EXCITING NEW RESEARCH ON THE USE OF CANNABIS ROOTS USED FOR ANTI-INFLAMMATORY MEDICATION!! 32 NEW COMPOUNDS WERE IDENTIFIED https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00168-3

A VERY IN-DEPTH ARTICLE ON TRICHOME DEVELOPMENT IN CANNABIS..... https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-023-00178-9

HERE IS AN INTERESTING ARTICLE I RECIEVED FROM ONE OFF MY JOURNALS...

THANKS FOR YOUR COMMENTS.....BEING A BIOPHARMACEUTICAL I BELIEVE IT PRUDENT TO ASSESS ALL DATA WHETHER IT BE POSITIVE AND/OR NEGATIVE.....EVERYTHING HAS RISKS.......WHAT WE CALL RISK BASED ASSESSMENT. BUT UNDERSTANDING THOSE RISKS CAN GUIDE YOU AND OTHERS LIKE YOU TO AN UNDERSTANDING ON HOW TO...

THIS IS A FAIRLY NEW WEBSITE DEDICATED TO CANNABIS...PSYCHEDELICS....AND OTHER PHARMACOLOGICAL SUBSTANCES.....THERE ARE SOME EXCELLENT RESOURCES.....ENJOY https://www.drugscience.org.uk/medical-psychedelics-working-group/